-
Something wrong with this record ?
Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons
V. Lacovich, SL. Espindola, M. Alloatti, V. Pozo Devoto, LE. Cromberg, ME. Čarná, G. Forte, JM. Gallo, L. Bruno, GB. Stokin, ME. Avale, TL. Falzone,
Language English Country United States
Document type Journal Article
NLK
Free Medical Journals
from 1981 to 6 months ago
PubMed Central
from 1981 to 6 months ago
Europe PubMed Central
from 1981 to 6 months ago
Open Access Digital Library
from 1981-01-01
Open Access Digital Library
from 1981-01-01
- MeSH
- Amyloid beta-Protein Precursor metabolism MeSH
- Axonal Transport physiology MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Mice MeSH
- Neurons metabolism ultrastructure MeSH
- Protein Isoforms MeSH
- tau Proteins metabolism MeSH
- Tauopathies metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Tau, as a microtubule (MT)-associated protein, participates in key neuronal functions such as the regulation of MT dynamics, axonal transport, and neurite outgrowth. Alternative splicing of exon 10 in the tau primary transcript gives rise to protein isoforms with three (3R) or four (4R) MT binding repeats. Although tau isoforms are balanced in the normal adult human brain, imbalances in 3R:4R ratio have been tightly associated with the pathogenesis of several neurodegenerative disorders, yet the underlying molecular mechanisms remain elusive. Several studies exploiting tau overexpression and/or mutations suggested that perturbations in tau metabolism impair axonal transport. Nevertheless, no physiological model has yet demonstrated the consequences of altering the endogenous relative content of tau isoforms over axonal transport regulation. Here, we addressed this issue using a trans-splicing strategy that allows modulating tau exon 10 inclusion/exclusion in differentiated human-derived neurons. Upon changes in 3R:4R tau relative content, neurons showed no morphological changes, but live imaging studies revealed that the dynamics of the amyloid precursor protein (APP) were significantly impaired. Single trajectory analyses of the moving vesicles showed that predominance of 3R tau favored the anterograde movement of APP vesicles, increasing anterograde run lengths and reducing retrograde runs and segmental velocities. Conversely, the imbalance toward the 4R isoform promoted a retrograde bias by a significant reduction of anterograde velocities. These findings suggest that changes in 3R:4R tau ratio has an impact on the regulation of axonal transport and specifically in APP dynamics, which might link tau isoform imbalances with APP abnormal metabolism in neurodegenerative processes. SIGNIFICANCE STATEMENT: The tau protein has a relevant role in the transport of cargos throughout neurons. Dysfunction in tau metabolism underlies several neurological disorders leading to dementia. In the adult human brain, two tau isoforms are found in equal amounts, whereas changes in such equilibrium have been associated with neurodegenerative diseases. We investigated the role of tau in human neurons in culture and found that perturbations in the endogenous balance of tau isoforms were sufficient to impair the transport of the Alzheimer's disease-related amyloid precursor protein (APP), although neuronal morphology was normal. Our results provide evidence of a direct relationship between tau isoform imbalance and defects in axonal transport, which induce an abnormal APP metabolism with important implications in neurodegeneration.
Centre for Translational Medicine Brno 65691 Czech Republic
Departamento de Física Buenos Aires C1428EGA Argentina and
Instituto de Biología Celular y Neurociencias Brno 65691 Czech Republic
Instituto de Biología Celular y Neurociencias Buenos Aires C1428ADN Argentina
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031167
- 003
- CZ-PrNML
- 005
- 20171027104307.0
- 007
- ta
- 008
- 171025s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1523/JNEUROSCI.2305-16.2016 $2 doi
- 035 __
- $a (PubMed)28053030
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Lacovich, Valentina $u Instituto de Biología Celular y Neurociencias (IBCN-CONICET-UBA), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires CP 1121, Argentina. Centre for Translational Medicine (CTM), International Clinical Research Center, St. Anne's University Hospital (ICRC-FNUSA), Brno 65691, Czech Republic.
- 245 10
- $a Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons / $c V. Lacovich, SL. Espindola, M. Alloatti, V. Pozo Devoto, LE. Cromberg, ME. Čarná, G. Forte, JM. Gallo, L. Bruno, GB. Stokin, ME. Avale, TL. Falzone,
- 520 9_
- $a Tau, as a microtubule (MT)-associated protein, participates in key neuronal functions such as the regulation of MT dynamics, axonal transport, and neurite outgrowth. Alternative splicing of exon 10 in the tau primary transcript gives rise to protein isoforms with three (3R) or four (4R) MT binding repeats. Although tau isoforms are balanced in the normal adult human brain, imbalances in 3R:4R ratio have been tightly associated with the pathogenesis of several neurodegenerative disorders, yet the underlying molecular mechanisms remain elusive. Several studies exploiting tau overexpression and/or mutations suggested that perturbations in tau metabolism impair axonal transport. Nevertheless, no physiological model has yet demonstrated the consequences of altering the endogenous relative content of tau isoforms over axonal transport regulation. Here, we addressed this issue using a trans-splicing strategy that allows modulating tau exon 10 inclusion/exclusion in differentiated human-derived neurons. Upon changes in 3R:4R tau relative content, neurons showed no morphological changes, but live imaging studies revealed that the dynamics of the amyloid precursor protein (APP) were significantly impaired. Single trajectory analyses of the moving vesicles showed that predominance of 3R tau favored the anterograde movement of APP vesicles, increasing anterograde run lengths and reducing retrograde runs and segmental velocities. Conversely, the imbalance toward the 4R isoform promoted a retrograde bias by a significant reduction of anterograde velocities. These findings suggest that changes in 3R:4R tau ratio has an impact on the regulation of axonal transport and specifically in APP dynamics, which might link tau isoform imbalances with APP abnormal metabolism in neurodegenerative processes. SIGNIFICANCE STATEMENT: The tau protein has a relevant role in the transport of cargos throughout neurons. Dysfunction in tau metabolism underlies several neurological disorders leading to dementia. In the adult human brain, two tau isoforms are found in equal amounts, whereas changes in such equilibrium have been associated with neurodegenerative diseases. We investigated the role of tau in human neurons in culture and found that perturbations in the endogenous balance of tau isoforms were sufficient to impair the transport of the Alzheimer's disease-related amyloid precursor protein (APP), although neuronal morphology was normal. Our results provide evidence of a direct relationship between tau isoform imbalance and defects in axonal transport, which induce an abnormal APP metabolism with important implications in neurodegeneration.
- 650 _2
- $a amyloidový prekurzorový protein beta $x metabolismus $7 D016564
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a axonální transport $x fyziologie $7 D001370
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a neurony $x metabolismus $x ultrastruktura $7 D009474
- 650 _2
- $a protein - isoformy $7 D020033
- 650 _2
- $a tauopatie $x metabolismus $7 D024801
- 650 _2
- $a proteiny tau $x metabolismus $7 D016875
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Espindola, Sonia L $u Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI-CONICET), Buenos Aires C1428ADN, Argentina.
- 700 1_
- $a Alloatti, Matías $u Instituto de Biología Celular y Neurociencias (IBCN-CONICET-UBA), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires CP 1121, Argentina. $7 gn_A_00004547
- 700 1_
- $a Pozo Devoto, Victorio $u Instituto de Biología Celular y Neurociencias (IBCN-CONICET-UBA), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires CP 1121, Argentina.
- 700 1_
- $a Cromberg, Lucas E $u Instituto de Biología Celular y Neurociencias (IBCN-CONICET-UBA), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires CP 1121, Argentina.
- 700 1_
- $a Čarná, Mária E $u Centre for Translational Medicine (CTM), International Clinical Research Center, St. Anne's University Hospital (ICRC-FNUSA), Brno 65691, Czech Republic.
- 700 1_
- $a Forte, Giancarlo $u Centre for Translational Medicine (CTM), International Clinical Research Center, St. Anne's University Hospital (ICRC-FNUSA), Brno 65691, Czech Republic.
- 700 1_
- $a Gallo, Jean-Marc $u Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 9NU, United Kingdom.
- 700 1_
- $a Bruno, Luciana $u Departamento de Física (IFIBA-CONICET), Facultad de Ciencias Exactas y Naturales (UBA), Buenos Aires C1428EGA, Argentina, and.
- 700 1_
- $a Stokin, Gorazd B $u Centre for Translational Medicine (CTM), International Clinical Research Center, St. Anne's University Hospital (ICRC-FNUSA), Brno 65691, Czech Republic.
- 700 1_
- $a Avale, M Elena $u Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI-CONICET), Buenos Aires C1428ADN, Argentina, tfalzone@fmed.uba.ar elena.avale@conicet.gov.ar. $7 gn_A_00010252
- 700 1_
- $a Falzone, Tomás L $u Instituto de Biología Celular y Neurociencias (IBCN-CONICET-UBA), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires CP 1121, Argentina, tfalzone@fmed.uba.ar elena.avale@conicet.gov.ar. Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires C1428ADN, Argentina.
- 773 0_
- $w MED00002840 $t The Journal of neuroscience the official journal of the Society for Neuroscience $x 1529-2401 $g Roč. 37, č. 1 (2017), s. 58-69
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28053030 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20171027104352 $b ABA008
- 999 __
- $a ok $b bmc $g 1254760 $s 992194
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 37 $c 1 $d 58-69 $i 1529-2401 $m The Journal of neuroscience $n J Neurosci $x MED00002840
- LZP __
- $a Pubmed-20171025